Botulinum toxin type A for preventing episodic migraine TS ID 11939Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Galcanezumab for migraine TS ID 10663Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
STS101 for treating acute migraine TS ID 11782Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Upadacitinib for treating giant cell arteritis TS ID 10495Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Zavegepant for treating acute migraine TSID 11998Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC